Every day patients receive treatments that do not work properly. For many this means no relief from symptoms, but for some death is the result. Yet concerted action against such products is limited. Before we can discuss why that's the case, I will attempt to explain what kind of products don’t work, and what we should call them.

Adequately funding the nation's patent system is the most important reform that could be enacted right now. Unfortunately, the legislation making its way through Congress may not do very much to help the situation.

Congress is in the process of rewriting the United States' patent laws. Scientific and technological changes in virtually all markets have dramatically altered the patent system itself. Reacting to fears that patents and patent litigation could retard rather than support technological progress, legislators are poised to take action with the...

The rapidly evolvingbiotech drugindustry requires policy to evolve with it, but there are dangers in changing laws too broadly, too fast.

India is on the brink of finalizing a free trade agreement with the European Union. Yet even as the deal gets close, one area remains hotly contested: protection for intellectual property (IP). Controversy mounts over "data exclusivity" for pharmaceuticals.

Congress is in the process of rewriting the United States' patent laws. Scientific and technological changes in virtually all markets have dramatically altered the patent system itself. Reacting to fears that patents and patent litigation could retard rather than support technological progress, legislators are poised to take action with the...

India has enormous potential for drug development if its legal system will respect intellectual property.

We are at a political impasse in the fight against fake drugs.